Updated Jul 16, 2026
Wentworth Kerry has filed 2 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $1.47M.
Kerry Wentworth is associated with Nuvation Bio Inc., a biotechnology company focused on developing innovative therapies for cancer treatment. Specific details about his role and contributions to the company are not widely documented.
| Role | Insider |
|---|---|
| Notability | 10/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-24 | NUVB | Nuvation Bio Inc. | S — Open-market sale | 63.0K | $6.02 | $379K |
| 2026-06-24 | NUVB | Nuvation Bio Inc. | M — Option exercise | 63.0K | $2.93 | $185K |
| 2026-04-21 | NUVB | Nuvation Bio Inc. | S — Open-market sale | 36.8K | $5.01 | $184K |
| 2026-04-21 | NUVB | Nuvation Bio Inc. | M — Option exercise | 36.8K | $2.93 | $108K |
| 2026-04-08 | NUVB | Nuvation Bio Inc. | S — Open-market sale [10b5-1] | 200.0K | $4.52 | $904K |
| 2026-04-08 | NUVB | Nuvation Bio Inc. | M — Option exercise [10b5-1] | 100.0K | $1.94 | $194K |
| 2026-04-08 | NUVB | Nuvation Bio Inc. | M — Option exercise [10b5-1] | 100.0K | $1.87 | $187K |
Kerry Wentworth is associated with Nuvation Bio Inc., a biotechnology company focused on developing innovative therapies for cancer treatment. Specific details about his role and contributions to the company are not widely documented.…
2 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 3 open-market sales ($1.47M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Wentworth Kerry profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.